Skip to main content
Premium Trial:

Request an Annual Quote

DNAStar, Wageningen University Broaden Licensing Agreement

NEW YORK (GenomeWeb News) – DNAStar said today that the Wageningen University and Research Centre in the Netherlands has inked a broad site-license agreement for DNAStar's Lasergene sequence-analysis software.

Under the terms of the license, all researchers in the Department of Agrotechnology and Food Sciences will have unlimited use of the software for their sequence-analysis projects.

The site license will include the latest version of Lasergene, which provides users with automated virtual MultiSite Gateway cloning capabilities and other features, Madison, Wis.-based DNAStar said.

In September 2008, Wageningen University licensed Lasergene for use among scientists at the Department of Plant Science and at Plant Research International, both part of the university.

Financial terms of the agreement were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.